EUR 18.38
(0.33%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 762.99 Million EUR | 11.57% |
2022 | 683.88 Million EUR | 19.18% |
2021 | 573.8 Million EUR | 3.21% |
2020 | 555.97 Million EUR | 3.98% |
2019 | 534.69 Million EUR | 13.36% |
2018 | 471.67 Million EUR | 7.95% |
2017 | 436.93 Million EUR | 3.58% |
2016 | 421.83 Million EUR | -10.82% |
2015 | 472.99 Million EUR | 5.8% |
2014 | 447.05 Million EUR | 15.78% |
2013 | 386.11 Million EUR | -29.41% |
2012 | 547.02 Million EUR | 11.11% |
2011 | 492.33 Million EUR | 16.1% |
2010 | 424.05 Million EUR | 8.37% |
2009 | 391.31 Million EUR | 10.38% |
2008 | 354.5 Million EUR | 16.47% |
2007 | 304.36 Million EUR | 9.89% |
2006 | 276.97 Million EUR | -2.22% |
2005 | 283.24 Million EUR | -0.01% |
2004 | 283.28 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 429.34 Million EUR | 0.0% |
2023 FY | 762.99 Million EUR | 11.57% |
2023 Q2 | 371.57 Million EUR | 0.0% |
2023 Q4 | 391.41 Million EUR | 0.0% |
2022 FY | 683.88 Million EUR | 19.18% |
2022 Q2 | 328.56 Million EUR | 0.0% |
2022 Q4 | 355.31 Million EUR | 0.0% |
2021 Q4 | 297.22 Million EUR | 0.0% |
2021 Q2 | 276.58 Million EUR | 0.0% |
2021 FY | 573.8 Million EUR | 3.21% |
2020 Q4 | 277.22 Million EUR | 0.0% |
2020 FY | 555.97 Million EUR | 3.98% |
2020 Q2 | 278.75 Million EUR | 0.0% |
2019 Q4 | 279.29 Million EUR | 0.0% |
2019 Q2 | 255.39 Million EUR | 0.0% |
2019 FY | 534.69 Million EUR | 13.36% |
2018 Q4 | - EUR | 0.0% |
2018 Q2 | 230.92 Million EUR | 0.0% |
2018 FY | 471.67 Million EUR | 7.95% |
2017 Q4 | 213.51 Million EUR | 0.0% |
2017 FY | 436.93 Million EUR | 3.58% |
2017 Q2 | 220.01 Million EUR | 0.0% |
2016 FY | 421.83 Million EUR | -10.82% |
2016 Q4 | 211.6 Million EUR | 0.0% |
2016 Q2 | 210.23 Million EUR | 0.0% |
2015 FY | 472.99 Million EUR | 5.8% |
2015 Q4 | 210.56 Million EUR | 0.0% |
2015 Q2 | 216.99 Million EUR | 0.0% |
2014 Q4 | 237.9 Million EUR | 0.0% |
2014 FY | 447.05 Million EUR | 15.78% |
2014 Q2 | 209.14 Million EUR | 0.0% |
2013 Q4 | 180.14 Million EUR | 0.0% |
2013 FY | 386.11 Million EUR | -29.41% |
2013 Q2 | 162.56 Million EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 547.02 Million EUR | 11.11% |
2012 Q2 | - EUR | 0.0% |
2011 FY | 492.33 Million EUR | 16.1% |
2011 Q2 | - EUR | 0.0% |
2010 Q4 | - EUR | 0.0% |
2010 FY | 424.05 Million EUR | 8.37% |
2010 Q2 | - EUR | 0.0% |
2009 FY | 391.31 Million EUR | 10.38% |
2009 Q4 | - EUR | 0.0% |
2008 FY | 354.5 Million EUR | 16.47% |
2007 FY | 304.36 Million EUR | 9.89% |
2006 FY | 276.97 Million EUR | -2.22% |
2005 FY | 283.24 Million EUR | -0.01% |
2004 FY | 283.28 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AB Science S.A. | 970 Thousand EUR | -78558.866% |
Boiron SA | 493.24 Million EUR | -54.687% |
Ipsen S.A. | 3.3 Billion EUR | 76.924% |
Malin Corporation plc | - EUR | -Infinity% |
Vetoquinol SA | 529.27 Million EUR | -44.159% |